Close

More on INCY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+132.4% Growth)
- Ratings (5.3 Score)
- Holders
- FDA

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/30/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INCY Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 580.1M
Marketable securities-available-for-sale 136.49M
Restricted cash and investments
Accounts receivable, net 131.52M
Prepaid expenses and other current assets 34.46M
Total current assets 886.66M
Restricted cash and investments
Property and equipment, net 151.94M
Other assets 2.56M
Total assets 1.54B
Current liabilities:
Accounts payable 57.52M
Accrued compensation 47.41M
Interest payable 2.29M
Accrued and other current liabilities 112.6M
Deferred revenue
Accrued restructuring
Total current liabilities 240.55M
Convertible senior notes 643.43M
Convertible subordinated notes
Deferred revenue
Total liabilities 1.17B
Stockholders' deficit:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; none issued or outstanding as of June 30, 2011 and December 31, 2010 0
Common stock, $0.001 par value; 400,000,000 shares authorized; 126,090,966 and 123,280,474 shares issued and outstanding as of June 30, 2011 and December 31, 2010, respectively 188K
Additional paid-in capital 2.05B
Accumulated other comprehensive gain 390K
Accumulated deficit -1.68B
Total stockholders' deficit
Total liabilities and stockholders' deficit 1.54B